Course of obstructive arterial pulmonary hypertension
Burkart, F.; Follath, F.; Jenzer, H.R.
Schweizerische Medizinische Wochenschrift 100(4): 146-148
1970
ISSN/ISBN: 0036-7672 PMID: 5495321 Document Number: 27340
Document emailed within 1 workday
Related Documents
Weitzenblum, E.; Hirth, C.; Ducolone, A.; Mirhom, R.; Rasaholinjanahary, J.; Pelletier, A. 1981: The prognostic significance of pulmonary arterial hypertension in chronic obstructive airway disease Le Poumon et le Coeur 37(3): 177-184Nikitin, A.V.; Marks, S.I. 2014: The application of chromo- and laserotherapy for the treatment of the patients presenting with chronic obstructive pulmonary disease and concomitant arterial hypertension Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 4: 3-6
Batyraliev, T.A.; Makhmutkhodzhaev, S.A.; Ekinsi, E.; Pataraia, S.A.; Pershukov, I.V.; Sidorenko, B.A.; Preobrazhenskiĭ, D.V. 2007: Pulmonary hypertension and right ventricular failure. Part XI. Endothelin receptor blockers in the treatment of primary pulmonary arterial hypertension Kardiologiia 47(7): 73-82
Batyraliev, T.A.; Makhmutkhodzhaev, S.A.; Ekence, E.; Pataraia, S.A.; Pershukov, I.V.; Sidorenko, B.A.; Preobrezhenskiĭ, D.V. 2007: Pulmonary hypertension and right ventricular failure. Part VIII. Diagnosis, course, and prognosis of primary (idiopathic) pulmonary arterial hypertension Kardiologiia 47(3): 69-78
Lewczuk, J.; Piszko, P.; Jagas, J.; Wrabec, K. 2005: Impact of 30 day therapy with doxazosin--alpha1 adrenergic blocker on pulmonary hemodynamics in patients with secondary pulmonary hypertension due to chronic obstructive pulmonary disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 18(105): 279-281
Rahimi-Rad, M.Hossein.; Rahimi, P.; Rahimi, B.; Gholamnaghad, M. 2014: Serum CA-125 level in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension Pneumologia 63(3): 164-166
Sarac, R.; Cikes, I.; Butković, D.; Dimov-Butković, D. 1995: Doppler echocardiography in the evaluation of pulmonary hypertension in chronic obstructive pulmonary disease Lijecnicki Vjesnik 117(1-2): 9-15
Karoli, N.A.; Rebrov, A.P. 2005: Some mechanisms of pulmonary hypertension development in patients with chronic obstructive pulmonary diseases Terapevticheskii Arkhiv 77(3): 87-93
Rahimi-Rad, M.H.; Rahimi, P.; Rahimi, B.; Gholamnaghad, M. 2014: Serum CA-125 level in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension Pneumologia 63(3): 164-166
Gassner, A.; Tizek, H.; Fridrich, L.; Pichler, M. 1985: Pulmonary hypertension and chronic obstructive ventilatory disorders--correlation between hemodynamic parameters and pulmonary function Schweizerische Medizinische Wochenschrift 115(8): 266-272
Marchman, H.B.; Skolnick, J.L. 1992: Blood pressure changes in patients with chronic obstructive pulmonary disease and hypertension completing phase II pulmonary rehabilitation Journal of the Kentucky Medical Association 90(10): 503-505
Bu, X.; Wang, C.; Pang, B. 2003: Effects of leukotriene receptor antagonist on chronic obstructive [correction of obstractive] pulmonary disease induced pulmonary hypertension Chinese Medical Journal 116(3): 459-461
Grützmacher, I.; Schicht, R.; Schlaeger, R.; Sill, V. 1984: Hemodynamics of pulmonary circulation in patients with chronic obstructive lung disease and pulmonary hypertension as dependent on the theophylline concentration of the serum Praxis und Klinik der Pneumologie 38(1): 19-25
Rubini, F.; Fonzo, R.; Dipino, G. 1989: Mechanical ventilation and pulmonary vascular resistance: comparison of IPPV, CPPV, CPAP, and PSV in decompensated chronic obstructive bronchopneumopathy with pulmonary hypertension Minerva Anestesiologica 55(11): 451-455
Volchkova, E.A.; Zateĭshchikova, A.A.; Shavrin, I.V.; Kiselev, D.G.; Brazhnik, V.A.; Privalov, D.V.; Doshchitsin, V.L.; Zateĭshchikov, D.A. 2012: Association of parameters of heart rate variability with severity of bronchial obstruction and presence of pulmonary hypertension in patients with chronic obstructive pulmonary disease Kardiologiia 52(7): 42-49
Kubyshkin, V.F.; Soldatchenko, S.S.; Konovalov, V.I. 1985: Chronic obstructive lung diseases associated with systemic arterial hypertension Terapevticheskii Arkhiv 57(2): 114-116
Rauscher, H.; Popp, W.; Vollmann, A.; Ritschka, L.; Zwick, H. 1989: Obstructive sleep apnea--a risk factor for arterial hypertension Wiener Klinische Wochenschrift 101(6): 200-203
Fong Chee Yee; Singham, K.T. 1986: Pulmonary valve echocardiogram in the evaluation of pulmonary arterial hypertension in the presence of intracardiac shunts Medical Journal of Malaysia 41(3): 198-204
Kadyraliev, T.K. 1990: The morphological changes in the pulmonary resistive vessels in the development of high-altitude pulmonary arterial hypertension Arkhiv Patologii 52(2): 36-40
Salgado-Escobar, J.L.; Ledesma-Velasco, M.; Munayer-Calderón, J.; Núñez-Garduño, D.; Salas-López, M.E.; Rodríguez-Hernández, L. 1987: Oxygen and tolazoline as vasodilators in pulmonary arterial hypertension secondary to high pulmonary blood flow Boletin Medico del Hospital Infantil de Mexico 44(3): 137-142